Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 4124263, 7 pages
http://dx.doi.org/10.1155/2016/4124263
Research Article

Identification of a Large SLC25A13 Deletion via Sophisticated Molecular Analyses Using Peripheral Blood Lymphocytes in an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD): A Clinical and Molecular Study

1Department of Pediatrics, The First Affiliated Hospital, Jinan University, Guangzhou 510630, China
2Core Laboratory, The First Affiliated Hospital, Jinan University, Guangzhou 510630, China
3Biomedical Translational Research Institute, Jinan University, Guangzhou 510630, China

Received 3 January 2016; Accepted 23 February 2016

Academic Editor: Patrizia Cardelli

Copyright © 2016 Qi-Qi Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Kobayashi, D. S. Sinasac, M. Iijima et al., “The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein,” Nature Genetics, vol. 22, no. 2, pp. 159–163, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Palmieri, B. Pardo, F. M. Lasorsa et al., “Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria,” The EMBO Journal, vol. 20, no. 18, pp. 5060–5069, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Ohura, K. Kobayashi, Y. Tazawa et al., “Neonatal presentation of adult-onset type II citrullinemia,” Human Genetics, vol. 108, no. 2, pp. 87–90, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Tazawa, K. Kobayashi, T. Ohura et al., “Infantile cholestatic jaundice associated with adult-onset type II citrullinemia,” The Journal of Pediatrics, vol. 138, no. 5, pp. 735–740, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Tomomasa, K. Kobayashi, H. Kaneko et al., “Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy,” The Journal of Pediatrics, vol. 138, no. 5, pp. 741–743, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Saheki and K. Kobayashi, “Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD),” Journal of Human Genetics, vol. 47, no. 7, pp. 333–341, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-Z. Song, M. Deng, F.-P. Chen et al., “Genotypic and phenotypic features of citrin deficiency: five-year experience in a Chinese pediatric center,” International Journal of Molecular Medicine, vol. 28, no. 1, pp. 33–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Kobayashi, T. Saheki, and Y. Z. Song, “Citrin deficiency,” in GeneReviews®, R. A. Pagon, M. P. Adam, H. H. Ardinger et al., Eds., University of Washington, Seattle, Wash, USA, 1993–2015. View at Google Scholar
  9. M. K. Thong, C. C. M. Boey, J. S. Sheng, M. Ushikai, and K. Kobayashi, “Neonatal intrahepatic cholestasis caused by citrin deficiency in two Malaysian siblings: outcome at one year of life,” Singapore Medical Journal, vol. 51, no. 1, pp. e12–e14, 2010. View at Google Scholar · View at Scopus
  10. B. H. Lee, H. Y. Jin, G.-H. Kim, J.-H. Choi, and H.-W. Yoo, “Nonalcoholic fatty liver disease in 2 siblings with adult-onset type II citrullinemia,” Journal of Pediatric Gastroenterology and Nutrition, vol. 50, no. 6, pp. 682–685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kikuchi, N. Arai-Ichinoi, O. Sakamoto et al., “Simple and rapid genetic testing for citrin deficiency by screening 11 prevalent mutations in SLC 25A13,” Molecular Genetics and Metabolism, vol. 105, no. 4, pp. 553–558, 2012. View at Google Scholar
  12. Z.-H. Zhang, W.-X. Lin, M. Deng et al., “Clinical, molecular and functional investigation on an infant with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD),” PLoS ONE, vol. 9, no. 2, Article ID e89267, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-H. Zhang, J.-Y. Gong, and J.-S. Wang, “Citrin deficiency presenting as acute liver failure in an eight-month-old infant,” World Journal of Gastroenterology, vol. 21, no. 23, pp. 7331–7334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Bijarnia-Mahay, J. Häberle, V. Rüfenacht, Y. Shigematsu, R. Saxena, and I. Verma, “Citrin deficiency: a treatable cause of acute psychosis in adults,” Neurology India, vol. 63, no. 2, pp. 220–222, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Dimmock, K. Kobayashi, M. Iijima et al., “Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet,” Pediatrics, vol. 119, no. 3, pp. e773–e777, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Hutchin, M. A. Preece, C. Hendriksz et al., “Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) as a cause of liver disease in infants in the UK,” Journal of Inherited Metabolic Disease, vol. 32, no. 1, supplement, pp. S151–S155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Fiermonte, G. Parisi, D. Martinelli et al., “A new Caucasian case of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD): a clinical, molecular, and functional study,” Molecular Genetics and Metabolism, vol. 104, no. 4, pp. 501–506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Vitoria, J. Dalmau, C. Ribes et al., “Citrin deficiency in a Romanian child living in Spain highlights the worldwide distribution of this defect and illustrates the value of nutritional therapy,” Molecular Genetics and Metabolism, vol. 110, no. 1-2, pp. 181–183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Avdjieva-Tzavella, M. B. Ivanova, T. P. Todorov et al., “First bulgarian case of citrin deficiency caused by one novel and one recurrent mutation in the SLC25A13 gene,” Genetic Counseling, vol. 25, no. 3, pp. 271–276, 2014. View at Google Scholar · View at Scopus
  20. D. Tokuhara, M. Iijima, A. Tamamori et al., “Novel diagnostic approach to citrin deficiency: analysis of citrin protein in lymphocytes,” Molecular Genetics and Metabolism, vol. 90, no. 1, pp. 30–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Tabata, J.-S. Sheng, M. Ushikai et al., “Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency,” Journal of Human Genetics, vol. 53, no. 6, pp. 534–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Z.-H. Zhang, W.-X. Lin, M. Deng, X.-J. Zhao, and Y.-Z. Song, “Molecular analysis of SLC25A13 gene in human peripheral blood lymphocytes: marked transcript diversity, and the feasibility of cDNA cloning as a diagnostic tool for citrin deficiency,” Gene, vol. 511, no. 2, pp. 227–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-X. Lin, Z.-H. Zhang, M. Deng, X.-R. Cai, and Y.-Z. Song, “Multiple ovarian antral follicles in a preterm infant with neonatal intrahepatic cholestasis caused by citrin deficiency: a clinical, genetic and transcriptional analysis,” Gene, vol. 505, no. 2, pp. 269–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-Z. Song, Z.-H. Zhang, W.-X. Lin et al., “SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China,” PLoS ONE, vol. 8, no. 9, Article ID e74544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-S. Zeng, S.-T. Zhao, M. Deng et al., “Inspissated bile syndrome in an infant with citrin deficiency and congenital anomalies of the biliary tract and esophagus: identification and pathogenicity analysis of a novel SLC25A13 mutation with incomplete penetrance,” International Journal of Molecular Medicine, vol. 34, no. 5, pp. 1241–1248, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. T. den Dunnen and S. E. Antonarakis, “Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion,” Human Mutation, vol. 15, no. 1, pp. 7–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. T. den Dunnen and E. Antonarakis, “Nomenclature for the description of human sequence variations,” Human Genetics, vol. 109, no. 1, pp. 121–124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Thangaratnarajah, J. J. Ruprecht, and E. R. S. Kunji, “Calcium-induced conformational changes of the regulatory domain of human mitochondrial aspartate/glutamate carriers,” Nature Communications, vol. 5, article 5491, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Ohura, K. Kobayashi, Y. Tazawa et al., “Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD),” Journal of Inherited Metabolic Disease, vol. 30, no. 2, pp. 139–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Z. Song, F. Wen, F. P. Chen, K. Kobayashi, and T. Saheki, “Neonatal intrahepatic cholestasis caused by citrin deficiency: efficacy of therapeutic formulas and update of clinical outcomes,” Japanese Journal for Inherited Metabolic Diseases, vol. 26, no. 1, pp. 57–69, 2010. View at Google Scholar
  31. K. Hayasaka, C. Numakura, K. Toyota, and T. Kimura, “Treatment with lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency,” in JIMD Reports—Case and Research Reports, 2011/2, SSIEM, Ed., vol. 2 of JIMD Reports, pp. 37–44, 2012. View at Publisher · View at Google Scholar
  32. P. A. Frey, “The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose,” The FASEB Journal, vol. 10, no. 4, pp. 461–470, 1996. View at Google Scholar · View at Scopus
  33. T. Saheki, K. Kobayashi, M. Iijima et al., “Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency,” Metabolic Brain Disease, vol. 17, no. 4, pp. 335–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. Y.-Z. Song, B.-X. Li, F.-P. Chen et al., “Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China,” Digestive and Liver Disease, vol. 41, no. 9, pp. 683–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Ning, R. Reynolds, J. Chen et al., “Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency,” Pediatric Research, vol. 48, no. 2, pp. 211–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Bosch, “Classical galactosaemia revisited,” Journal of Inherited Metabolic Disease, vol. 29, no. 4, pp. 516–525, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Hayasaka, C. Numakura, and H. Watanabe, “Treatment and pathomechanism of citrin deficiency,” Brain and Nerve, vol. 67, no. 6, pp. 739–747, 2015. View at Google Scholar · View at Scopus